the 58 year story of Psychology Today
What I learned analysing this hypothetical deal
The story of social disconnection, what's worked, what hasn't and what can we do next
Pricing, Mr. Macro, specialty services and more...
Results from our research with 460 real people
Four hard questions every UK mental health operator should ask themselves
Revenue growth, profitability and cashflow... and yet the worst valuation in mental health
a pharma market with a twist
Neurotech, Gen-AI, metabolic psychiatry and more...
How to understand market fundamentals to design better strategy in mental health
+ funding for novel target validation for mental health drug discovery
The bull case, bear case and my verdict on this deal
